Pfizer (PFE) Tops Q3 EPS by 1c, Updates FY Guidance
Get Alerts PFE Hot Sheet
Price: $29.85 -0.86%
Revenue Growth %: -4.7%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
FNLC, LSBK, OVLY, More
Revenue Growth %: -4.7%
Financial Fact:
Discontinued operations--net of tax: 0
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q3 EPS of $0.72, $0.01 better than the analyst estimate of $0.71. Revenue for the quarter came in at $12.1 billion versus the consensus estimate of $12.33 billion.
GUIDANCE:
Pfizer sees FY2020 EPS of $2.88-$2.93, versus the consensus of $2.90. Pfizer sees FY2020 revenue of $48.8-49.5 billion, versus the consensus of $49.34 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Hexcel falls on revenue miss and weak guidance
- Southern Missouri Bancorp (SMBC) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share